Recursion Pharmaceuticals Equity Ratio

Equity Ratio of Recursion Pharmaceuticals is 76.71 % in 2026.

Equity Ratio of Recursion Pharmaceuticals changed from 71.43 % to 76.71 %, representing a 7.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Recursion Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.